Literature DB >> 18460788

Characterization of mouse sialyltransferase genes: their evolution and diversity.

Shou Takashima1.   

Abstract

Sialic acids are negatively charged acidic sugars, and sialylglycoconjugates often play important roles in various biological phenomena. Sialyltransferases are involved in the synthesis of sialylglycoconjugates, and 20 members of the mammalian sialyltransferase family have been identified to date. These sialyltransferases are grouped into four families according to the carbohydrate linkages they synthesize: beta-galactoside alpha2,3-sialyltransferases (ST3Gal I-VI), beta-galactoside alpha2,6-sialyltransferases (ST6Gal I and II), GalNAc alpha2,6-sialyltransferases (ST6GalNAc I-VI), and alpha2,8-sialyltransferases (ST8Sia I-VI). Analysis of the amino acid sequence similarities, substrate specificities, and gene structures of mouse sialyltransferases has revealed that they can be further divided into seven subfamilies. The genomic structural resemblance of members of the same subfamily suggests that they arose from a common ancestral gene through gene duplication events. These multiple sialyltransferase genes are needed for fine control of the expression of sialylglycoconjugates, resulting in a variety of developmental stage- and tissue-specific glycosylation patterns.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460788     DOI: 10.1271/bbb.80025

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  50 in total

1.  ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.

Authors:  Zhongyu Liu; Amanda F Swindall; Robert A Kesterson; Trenton R Schoeb; Daniel C Bullard; Susan L Bellis
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

3.  Selective exo-enzymatic labeling of N-glycans on the surface of living cells by recombinant ST6Gal I.

Authors:  Ngalle Eric Mbua; Xiuru Li; Heather R Flanagan-Steet; Lu Meng; Kazuhiro Aoki; Kelley W Moremen; Margreet A Wolfert; Richard Steet; Geert-Jan Boons
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-15       Impact factor: 15.336

4.  Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

5.  Globally profiling sialylation status of macrophages upon statin treatment.

Authors:  Dan Wang; Huan Nie; Evgeny Ozhegov; Lin Wang; Aimin Zhou; Yu Li; Xue-Long Sun
Journal:  Glycobiology       Date:  2015-06-01       Impact factor: 4.313

Review 6.  Golgi glycosylation.

Authors:  Pamela Stanley
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

Review 7.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

8.  The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.

Authors:  Kathryn H Condon; Jianghai Ho; Camenzind G Robinson; Cyril Hanus; Michael D Ehlers
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

9.  Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.

Authors:  Maho Suzukawa; Marina Miller; Peter Rosenthal; Jae Youn Cho; Taylor A Doherty; Ajit Varki; David Broide
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

10.  Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure.

Authors:  Wei Deng; Andrew R Ednie; Jianyong Qi; Eric S Bennett
Journal:  Basic Res Cardiol       Date:  2016-08-09       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.